Developing Biomarkers of Dietary Intake

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)

Overall Status

Completed

CT.gov ID

NCT01237093

Collaborator

(none)

Enrollment

Location

Arms

113.2

Duration (Months)

0.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Background:

Researchers who study health and nutrition are interested in developing more accurate methods of determining what people eat from day to day and how it affects their general health. In particular, better methods are needed to determine if people are accurately remembering what they ate. One possible method involves the use of biomarkers, or indicators in urine, blood, saliva, fat, and hair, which are related to the intake of a particular food in a consistent way. One set of biomarkers in blood samples and hair may be used to determine the relative amount of meat, fish, and soda (corn/sugar cane) in a person s diet. However, more research is needed to study the effectiveness of using these biomarkers to accurately track dietary intake.

Objectives:

To validate the use of biomarkers as representative of specific dietary intake patterns (meat/fish/soda).

Eligibility:

Healthy, nondiabetic men between 18 and 65 years of age.

Design:

This study involves an initial screening visit and a 12-13 week inpatient dietary study period.
Participants will be screened with a medical history and physical examination, as well as blood and urine samples and a glucose tolerance test to exclude individuals who have diabetes.
After 3 days of a standard weight-maintaining diet, participants will have a glucose tolerance test and a body fat scan; provide hair, blood, and fat tissue samples; and complete questionnaires and performance tests.
Participants will spend one day in a metabolic chamber to measure their energy expenditure and general metabolism.
Participants will then be randomized into one of eight carefully designed diets for 12 weeks. The diets will differ in the amount of meat, fish, and soda, including one diet where none of the three biomarker-related foods will be permitted. Blood samples will be collected throughout the study diet period.
At the end of the 12-week study diet period, participants will provide additional hair, blood, and fat tissue samples, and will have a second metabolism assessment in the metabolic chamber.

Condition or Disease	Intervention/Treatment	Phase
Diet Therapy Healthy Volunteers	Other: 1. Meat, no fish or soda Other: 2. Meat and soda, no fish Other: 3. Meat and fish, no soda Other: 4. Meat and fish and soda Other: 5. Fish, no meat or soda Other: 6. Fish and soda, no meat Other: 7. No meat, fish or soda Other: 8. Soda, no meat or fish	Phase 1

Detailed Description

Studies of health and nutrition use a variety of tools to determine what people eat from day to day. Unfortunately, most of the methods used are not accurate for a variety of reasons and do not provide solid information on which to base health recommendations or public policy. In general, when people are asked to keep track of what they eat or recall what they have eaten in the past, they make mistakes in estimating both amounts and specifics of what was eaten. New tools that can help determine if people are accurately remembering what they ate are desperately needed.

Biomarkers are things that can be measured (in urine, blood, hair, etc.) which are related to the intake of a particular food in a consistent way and may therefore be more accurate than a food record. One set of biomarkers that may be used are naturally occurring (present in all foods) stable isotopes of carbon and nitrogen to determine the relative amount of meat, fish, and soda (corn/sugar cane) in a person s diet. These isotopes can be measured in blood samples and hair.

The aim of this study is to validate the use of stable isotope biomarkers as representative of specific dietary intake patterns (meat/fish/soda). This study will be an inpatient study in which highly specific diets will be fed to volunteers for ~12 weeks and stable isotopes will be measured in blood and hair. The ultimate goal is to develop biomarkers to be used to validate food intake patterns in outpatient clinical and epidemiological studies.

Study Design

Study Type:

Interventional

Actual Enrollment :

59 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Basic Science

Official Title:

Developing Biomarkers of Dietary Intake

Study Start Date :

Oct 24, 2010

Actual Primary Completion Date :

Mar 31, 2020

Actual Study Completion Date :

Mar 31, 2020

Arms and Interventions

Arm	Intervention/Treatment
Experimental: 1. Meat, no fish or soda weight maintaining diet with meat but no fish or soda for 12 weeks	Other: 1. Meat, no fish or soda weight maintaining diet with meat but no fish or soda
Experimental: 2. Meat and soda, no fish weight maintaining diet with meat and soda but no fish for 12 weeks	Other: 2. Meat and soda, no fish weight maintaining diet with meat and soda but no fish
Experimental: 4. Meat and fish and soda weight maintaining diet with meat, fish, and soda for 12 weeks	Other: 4. Meat and fish and soda weight maintaining diet with meat, fish and soda
Experimental: 5. Fish, no meat or soda weight maintaining diet with meat, fish, and soda for 12 weeks	Other: 5. Fish, no meat or soda weight maintaining diet with fish but no meat or soda
Experimental: 6. Fish and soda, no meat weight maintaining diet with fish and soda but no meat for 12 weeks	Other: 6. Fish and soda, no meat weight maintaining diet with fish and soda but no meat
Experimental: 7. No meat, fish, or soda no fish, and no soda (vegetarian) for 12 weeks	Other: 7. No meat, fish or soda weight maintaining diet with no meat, no fish, and no soda (vegetarian)
Experimental: 8. Soda, no meart or fish weight maintaining diet with soda but no meat or fish (vegetarian + soda) for 12 weeks	Other: 8. Soda, no meat or fish weight maintaining diet with soda but no meat or fish (vegetarian + soda)
Experimental: Meat and fish, no soda weight maintaining diet with meat and fish but no soda for 12 weeks	Other: 3. Meat and fish, no soda weight maintaining diet with meat and fish but no soda

Outcome Measures

Primary Outcome Measures

Change in NIR [Weeks 0, 2, 4, 6, 8, 10, 12]
Change in nitrogen stable isotope rations (N15/N14)
Change in CR [Weeks 0, 2, 4, 6, 8, 10, 12]
Change in carbon stable isotope ratios (13C/12C)

Secondary Outcome Measures

Performance tests [Weeks 0 and 12]
Iowa Card Setting Test, Stroop Color Word Test, Wisconsin Card Sorting Test, Go/No Go Task
OGTT [Weeks 0 and 12]
Lipid panel [Weeks 0 and 12]
LDL, HDL, Triglycerides and Total Cholesterol
Respiratory quotient (RQ) [Weeks 0 and 12]
Ratio of the volume of carbon dioxide (CO2) produced to the volume of oxygen (O2) used, or VCO2/VO2

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 65 Years

Sexes Eligible for Study:

Male

Accepts Healthy Volunteers:

INCLUSION CRITERIA:
Body mass index less than or equal to 35 kg/m(2) to minimize the impact of body size on isotope measurements.
Males 18-65 years old will be recruited for this study. Minors under the age of 18 will be excluded because the time requirements of the study are such that they would interfere with school schedules.

Healthy, as determined by medical history, physical examination, and laboratory tests.

EXCLUSION CRITERIA:

Current smoking
Female sex
Baldness or hair less than 2 cm in length
Medically- or self-imposed dietary restrictions that would limit a participant s ability/willingness to consume the diet to which they are randomized.
Type 2 diabetes (according to the World Health Organization diagnostic criteria)
Endocrine disorders (Cushing s Disease, pituitary disorders, and hypo- and hyperthyroidism)
Chronic pulmonary disorders, including chronic obstructive pulmonary disease, that would limit ability to follow the protocol (investigator judgment) and obstructive sleep apnea syndrome; only subjects with mild or exercise-induced asthma on no medications or on beta-adrenergic agonists only (such as albuterol) will be allowed to enter the study (provided use of these agents is not required for one week before study entry).
Cardiovascular diseases (coronary heart disease, heart failure, arrhythmias, and peripheral artery disease)
Hypertension (blood pressure measurement higher than 140/90 mm Hg on two or more occasions or use of anti-hypertensive medications)
Diagnosed gastrointestinal diseases, including inflammatory bowel diseases (e.g., Crohn s disease and ulcerative colitis), malabsorption syndromes (e.g., celiac disease), gastric ulcer (active); only subjects with gastro-esophageal reflux will be allowed to enter the study
Presence of a pacemaker or other implantable devices
Liver disease (cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 1.5 x normal)
Renal disease (serum creatinine concentrations greater than or equal to 1.5 mg/dl and/or greater than 100mg/dl of protein based on urine dipstick)
Central nervous system disease (cerebrovascular accidents, dementia, and neurodegenerative disorders)
Cancer requiring treatment in the past five years, except for non-melanoma skin cancers or cancers that have clearly been cured or in the opinion of the investigator carry an excellent prognosis
Alcohol (more than 3 drinks per day) and/or drug abuse (such as amphetamines, cocaine, heroin, or marijuana)
Current or past history of: bipolar disorder, schizophrenia or presence of psychotic symptoms, bulimia nervosa or anorexia nervosa, or current major depressive disorder
Weight change of plus or minus 5% in the last 3 months

Conditions not specifically mentioned above may serve as criteria for exclusion at the discretion of the investigators. Additionally, potential subjects might be excluded if they demonstrate a style of interpersonal relationships that would inhibit successful completion of the study.

Non-English speaking subjects as a population will be excluded from participation in this protocol. One of the secondary hypotheses of the protocol relates to a battery of psychological questionnaires and performances tests which are administered to the volunteers at the beginning and end of the study. There are currently no validated, translated forms of these questionnaires and tests available; therefore we will restrict enrollment to English speaking subjects only.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	NIDDK, Phoenix	Phoenix	Arizona	United States	85014

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

Principal Investigator: Susanne Votruba, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

ClinicalTrials.gov Identifier:

NCT01237093

Other Study ID Numbers:

999911018
11-DK-N018

First Posted:

Nov 9, 2010

Last Update Posted:

Aug 25, 2022

Last Verified:

Jun 21, 2022

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Study Results

No Results Posted as of Aug 25, 2022